home ver. 2.3. site index contact us

Message from the CEO
How We Work
Business Integrity
History of Schering-Plough
Management Team
Schering-Plough Worldwide
Speeches & Presentations
The Schering-Plough Foundation
Diversity & Inclusion
Supplier Registration
Diversity Colleague Demographics

Management Biographies

ELLEN GEISEL
Senior Vice President, Primary Care Customer Group
Global Pharmaceutical Business
Schering-Plough Corporation
Kenilworth, New Jersey

Ellen Geisel is senior vice president, Primary Care Customer Group, for the Global Pharmaceutical Business of Schering-Plough Corporation.

Geisel joined Schering-Plough in July 2003. She oversees the company's primary care products, international OTC (over-the-counter) business, and sales and consumer communications initiatives. She also has responsibility for marketing excellence on a global basis.

Previously, Geisel was senior vice president of customer communications for Pharmacia Corporation. Prior to her employment with Pharmacia Corporation, Geisel held management positions at Wyeth Pharmaceuticals, Earle Palmer Brown and SmithKline Consumer Products, a division of GlaxoSmithKline.

Geisel has 28 years of pharmaceutical experience spanning sales, product management, market research, and professional and consumer marketing communications.

She holds a B.A. degree in sociology from the College of Saint Elizabeth, Convent Station, N.J., and an M.B.A. degree in marketing from La Salle University Graduate Business School, Philadelphia.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

 

Spotlight On

Combination Brochure

Brochure on the Combination

Basic Facts and Figures
•  World Headquarters:
2000 Galloping Hill Road, Kenilworth, N.J. 07033-0530
•  Chairman and CEO:
Fred Hassan
Number of employees:
55,000
Net sales (2007):
$12.7 billion
Business operations in more than:
140 countries
Largest-selling products:
VYTORIN*, ZETIA*, REMICADE, NASONEX.
R&D investment (2007):
$2.9 billion
Areas of research:
cardiovascular disease, central nervous system disorders, immunology and infectious disease, oncology, respiratory diseases and women's health

*VYTORIN and ZETIA are managed through a joint venture with Merck & Co., Inc. Schering-Plough accounts for the joint venture under the Equity method. Total cholesterol joint venture sales were $5.2 billion in 2007.
 
                                      © 2003-2008 Schering-Plough Corporation.
                 Please see our legal notice, privacy policy and forward-looking statement.
Schering-Plough Schering-Plough skip to content Schering-Plough